Outcome of C3 glomerulopathy patients: largest single-centre experience from South Asia

• Published in: Journal of nephrology 2020-06, Vol.33 (3), p.539-550
• Main Authors: Kumar, Ashwani, Nada, Ritambhra, Ramachandran, Raja, Rawat, Amit, Tiewsoh, Karalanglin, Das, Reena, Rayat, Charan Singh, Gupta, Krishan Lal, Vasishta, Rakesh Kumar
• Format: Article
• Language: English
• Subjects: Medicine; Medicine & Public Health; Nephrology; Original Article; Urology
• ISSN: 1121-8428; 1724-6059
• DOI: 10.1007/s40620-019-00672-5

Background C3 glomerulopathy (C3G) is related to dysfunction of alternative complement pathway (ACP) because of its hyperactivation. Triggering factors and genetic profile are likely to be different in developing countries as compared to the Western world. Data regarding C3G from South Asian is scanty. Study design In the present study, 115 patients of C3G from 2012 to 2017 were analyzed. Clinical details were reviewed; serological levels of C3, C4, complement factor H or B and autoantibody testing was done by nephelometry/ELISA. Limited genetics workup for CFH and CFHR5 genes was done. Results The prevalence of C3G was 1.52%. There was no difference in demographic and histopathologic profiles of C3G patients. Majority of patients had low functional assay and C3 levels. C3 nephritic factor was present in 47.5% of DDD and 38.6% of C3GN. Autoantibodies to CFH were present more often in the patients of C3GN (29.5%) than DDD (12.5%). Autoantibodies to CFB were equally common in both groups. Past history of infections was present in one-third patients and monoclonal paraproteins were present only in two patients. No pathogenic variants were noted in CFH/CFHR5 gene. On follow-up (3.2 + 1.6 years), complete and partial remission was achieved in one-fourth patients and 26% had resistance disease. About 40% progressed to ESRD and 18 underwent renal transplantation of which nine had a post-transplant recurrence. Conclusions Indian cohort had some differences in the immunological and genetic profile when compared to the Western literature; most significant was the absence of monoclonal immunoglobulins as a trigger for C3G.